252 related articles for article (PubMed ID: 35768814)
1. Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values.
Hu LT; Deng WJ; Chu ZS; Sun L; Zhang CB; Lu SZ; Weng JR; Ren QS; Dong XY; Li WD; Li XB; Du YT; Li Y; Wang WQ
BMC Pulm Med; 2022 Jun; 22(1):259. PubMed ID: 35768814
[TBL] [Abstract][Full Text] [Related]
2. Characterization of the prognostic values of CXCR family in gastric cancer.
Yu C; Zhang Y
Cytokine; 2019 Nov; 123():154785. PubMed ID: 31344595
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Prognostic Values of the CXCR1-7 in Clear Cell Renal Cell Carcinoma (ccRCC) Microenvironment.
Wu Z; Zhang Y; Chen X; Tan W; He L; Peng L
Front Mol Biosci; 2020; 7():601206. PubMed ID: 33324682
[No Abstract] [Full Text] [Related]
4. CXCR4 and CXCR3 are two distinct prognostic biomarkers in breast cancer: Database mining for CXCR family members.
Guo K; Feng G; Yan Q; Sun L; Zhang K; Shen F; Shen M; Ruan S
Mol Med Rep; 2019 Dec; 20(6):4791-4802. PubMed ID: 31702806
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of clinical prognosis and CLIC1 immune invasion in lung adenocarcinoma.
Chen Z; Chen W; Huang R; Chen D; Li Z; Qi X; Sun L; Lin L; Zhang Z
Medicine (Baltimore); 2022 Sep; 101(39):e30760. PubMed ID: 36181109
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of SEC61G in lung adenocarcinoma: a comprehensive study based on bioinformatics and in vitro validation.
Zheng Q; Wang Z; Zhang M; Yu Y; Chen R; Lu T; Liu L; Ma J; Liu T; Zheng H; Li H; Li J
BMC Cancer; 2021 Nov; 21(1):1216. PubMed ID: 34774014
[TBL] [Abstract][Full Text] [Related]
7. Determination of Potential Therapeutic Targets and Prognostic Markers of Ovarian Cancer by Bioinformatics Analysis.
Zhang J; Huang S; Quan L; Meng Q; Wang H; Wang J; Chen J
Biomed Res Int; 2021; 2021():8883800. PubMed ID: 33829065
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
10. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
11. Expression and Prognostic Significance of m6A-Related Genes in Lung Adenocarcinoma.
Zhang Y; Liu X; Liu L; Li J; Hu Q; Sun R
Med Sci Monit; 2020 Feb; 26():e919644. PubMed ID: 32086933
[TBL] [Abstract][Full Text] [Related]
12. High GJB2 mRNA expression and its prognostic significance in lung adenocarcinoma: a study based on the TCGA database.
Tang Y; Zhang YJ; Wu ZH
Medicine (Baltimore); 2020 Apr; 99(14):e19054. PubMed ID: 32243356
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive analysis of the prognostic value and immune function of chemokine-CXC receptor family members in breast cancer.
Lyu L; Zheng Y; Hong Y; Wang M; Deng Y; Wu Y; Xu P; Yang S; Wang S; Yao J; Zhang D; Guo Y; Lyu J; Dai Z
Int Immunopharmacol; 2020 Oct; 87():106797. PubMed ID: 32702599
[TBL] [Abstract][Full Text] [Related]
14. EZH2 as a prognostic-related biomarker in lung adenocarcinoma correlating with cell cycle and immune infiltrates.
Fan K; Zhang BH; Han D; Sun YC
BMC Bioinformatics; 2023 Apr; 24(1):149. PubMed ID: 37069494
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
16. Analysis of C-X-C motif chemokine receptors in breast cancer: potential value in immunotherapy and prognostic prediction.
Sun Y; Yang M; Zhang Q
Ann Transl Med; 2022 Dec; 10(24):1379. PubMed ID: 36660642
[TBL] [Abstract][Full Text] [Related]
17. DPYSL2 as potential diagnostic and prognostic biomarker linked to immune infiltration in lung adenocarcinoma.
Wu YJ; Nai AT; He GC; Xiao F; Li ZM; Tang SY; Liu YP; Ai XH
World J Surg Oncol; 2021 Sep; 19(1):274. PubMed ID: 34517904
[TBL] [Abstract][Full Text] [Related]
18. System analysis of
Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z
Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116
[TBL] [Abstract][Full Text] [Related]
19. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-Cancer Analysis.
Liu TT; Li R; Huo C; Li JP; Yao J; Ji XL; Qu YQ
Front Cell Dev Biol; 2021; 9():682002. PubMed ID: 34409029
[TBL] [Abstract][Full Text] [Related]
20. The High Expression of PTPRH Is Associated with Poor Prognosis of Human Lung Adenocarcinoma.
Chen A; Ding S; Shen X; Lin X
Comput Math Methods Med; 2021; 2021():9932088. PubMed ID: 34367321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]